Supporting cancer research in Switzerland

When INTEGRA Biosciences launched the PIPETGIRL in 2015, the company pledged to donate 10€ / US$15 from every sale to internationally renowned research institutes dedicated to finding a cure for breast cancer. This limited edition version of the PIPETBOY acu 2 pipetting controller is still available today, and the company’s latest donation of 20,000 CHF has been awarded to the Swiss Cancer League (Krebsliga Schweiz).

The Swiss Cancer League is using this money to help fund a project investigating the link between E3 ubiquitin ligases and breast carcinoma. The research, being conducted at ETH Zurich, aims to develop a comprehensive preclinical model of hGID E3 ubiquitin ligase function – which is highly over-expressed in up to 55% of aggressive breast, ovarian and prostate cancers – to help unravel its role in tumour progression and metastasis in breast cancer cells. This model will then be used to develop prognostic markers of cancer progression, and to screen for compounds that may form the basis of a future therapeutic intervention.

 

Other news

Upcoming Events

IBMS Biomedical Science Congress

ICC, Birmingham
22-25 September 2019

Lab Innovations

NEC, Birmingham (Hall 12)
30 & 31 October 2019

The genomic and molecular revolution in microbiology: in technology we trust (or do we?).

RAF Museum, Hendon, London
14 May 2020

Clinical and Laboratory Haemostasis 2020

STEM/Atrium Conference Centre, Sheffield Hallam University
3-4 June 2020

Latest Issue

Pathology In Practice

Pathology In Practice

Aug 2019

Meet Epredia: introducing a team you already know

Register now to apply for regular copies of Pathology In Practice and free access to premium content, as well as our regular newsletters.